Shares of Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report) dropped 6% during mid-day trading on Thursday . The stock traded as low as $0.47 and last traded at $0.47. Approximately 500 shares changed hands during trading, a decline of 98% from the average daily volume of 20,342 shares. The stock had previously closed at $0.50.
Cell MedX Price Performance
The business has a 50-day moving average price of $0.33 and a 200 day moving average price of $0.13.
About Cell MedX
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Recommended Stories
- Five stocks we like better than Cell MedX
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- The Basics of Support and Resistance
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
